Molgen Presents Diagnostics Chemistry, Flows and Systems at MEDICA 2021
|
By LabMedica International staff writers Posted on 15 Nov 2021 |

MolGen B.V. (Veenendaal, Netherlands) presented its diagnostics chemistry, flows and systems at MEDICA 2021, the largest medical trade fair in the world that has been taking place for more than four decades. Over the years, the event has attracted several thousand exhibitors from more than 50 countries. Leading individuals from the fields of business, research, and politics attended MEDICA 2021, alongside tens of thousands of national and international experts and decision-makers from the sector. MolGen took advantage of the opportunity to connect with the global leaders in clinical chemistry, molecular diagnostics, translational medicine, lab management, and other areas of breaking science in laboratory medicine.
At MEDICA 2021, MolGen showcased and demonstrated its latest products and services, including technology, systems, reagents and consumables for human diagnostics and pharmaceutical sciences. MolGen demonstrated its PurePrep 96 automated DNA and RNA purification system which is suitable for high throughput workflows with up to 96 samples per run and process samples up to 1ml. The device uses magnetic separation technology for different matrices like blood, cultured cells, bacteria, tissues, cell-free body fluids, and plant samples. The small-footprint system enables high-speed, high-quality processing with magnetic rods used to transfer magnetic beads through the various purification phases of mixing, binding, washing and elution resulting in purified DNA and RNA.
MolGen also showcased its PurePrep TTR high throughput automated liquid handling device that transfers liquid fast, accurately, and consistently from tubes to Deep Well microtiter plates. Both the tubes and plates are equipped with barcodes read by scanners to track and trace samples throughout the complete workflow. This system is developed to decrease the hands-on time, increase the lab’s accuracy, reduce contamination risks by decapping and capping tubes, and transfer samples from the tubes to plates. It is optimized for processing PurePrep TL+ samples.
Additionally, MolGen highlighted its PurePrep FR automated liquid handler for filling plates with high precision and decreasing hands-on time. It is ideal for downstream processing setups, like the PCR and LAMP setup. This system is easy to adjust to different procedures and provides insight into the results. Also on display was the MolGen Sealer, a semi-automatic thermal sealer which is ideal for low to medium throughput laboratories that requires uniform and consistent sealing of micro-plates. Unlike manual plate sealing, the MolGen Sealer produces consistent plate seals. With flexible temperature, time and pressure settings, the sealing conditions are easily optimized to guarantee consistent results, produce 100% tight seals, and eliminate sample loss or evaporation. Offering complete versatility, the MolGen Sealer is compatible with a full range of plates for PCR, assay or storage applications, and can be used with plates ranging from standard height to deep well.
Related Links:
MolGen B.V.
Latest Clinical Chem. News
- New CA19-9 Cutoff Value Helps Identify High-Risk Pancreatic Cancer Patients
- Blood-Based Biomarkers Show Promise for Psychosis Risk Prediction
- International Experts Recommend Ending Routine 'Corrected' Calcium Reporting
- Long-Term Data Show PSA Screening Modestly Reduces Prostate Cancer Deaths
- Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively
- FDA-Cleared Assay Enables Comprehensive Automated Testosterone Testing
- CE-Marked Blood Biomarker Test Advances Automated Alzheimer’s Diagnostics
- Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection
- Noninvasive Urine Test May Support Earlier Diagnosis of Psychiatric Disorders
- At-Home Blood and Cognitive Tests Support Dementia Risk Stratification
- Ultrasensitive Test Detects Key Biomarker of Frontotemporal Dementia Subtype
- Routine Blood Tests Years Before Pregnancy Could Identify Preeclampsia Risk
- Blood Test Detects Testicular Cancer Missed by Standard Markers
- Routine Blood Tests Identify Biomarkers Linked to PTSD
- Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges
- Routine Blood Count Ratio Linked to Future Alzheimer’s and Dementia Risk
Channels
Clinical Chemistry
view channel
New CA19-9 Cutoff Value Helps Identify High-Risk Pancreatic Cancer Patients
Pancreatic ductal adenocarcinoma (PDAC) is frequently diagnosed at an advanced stage and remains one of the most lethal solid tumors. Clinicians commonly use serum carbohydrate antigen 19-9 (CA19-9) to... Read more
Blood-Based Biomarkers Show Promise for Psychosis Risk Prediction
Psychosis commonly emerges in adolescence or early adulthood and can severely disrupt social and occupational functioning. Hallucinations, delusions, and disorganized thinking often evolve gradually, hindering... Read moreMolecular Diagnostics
view channel
New RNA Origami Method Supports Faster Targeted Testing for Repeat Expansion Disorders
Repeat expansion disorders drive conditions such as myotonic dystrophy, Huntington’s disease, and amyotrophic lateral sclerosis (ALS), yet accurately sizing the mutated sequences remains difficult.... Read more
FDA Approves Expanded Liquid Biopsy Panel for Advanced Cancer Profiling
Timely, comprehensive tumor profiling helps clinicians make treatment selection decisions for patients with advanced cancer. Blood-based approaches can provide actionable insights from a simple draw and... Read moreHematology
view channel
Higher Ferritin Threshold May Improve Iron Deficiency Detection in Children
Iron deficiency in school-age children can affect brain development, learning, growth, and physical performance, yet early deficiency may be missed when screening focuses mainly on anemia.... Read more
Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is an aggressive blood cancer that most often affects older adults and still carries a poor prognosis despite therapeutic advances. Venetoclax-based regimens have improved... Read moreImmunology
view channel
Immune Enzyme Linked to Treatment-Resistant Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) affects nearly 3 million people in the United States and its prevalence continues to rise. Medications that target tumor necrosis factor (TNF)-alpha are widely used, but... Read more
Simple Blood Test Could Replace Biopsies for Lung Transplant Rejection Monitoring
Lung transplant recipients face some of the highest rates of acute cellular rejection, and routine surveillance often relies on repeated surgical biopsies. These procedures can cause complications such... Read moreMicrobiology
view channel
New AMR Assay Supports Rapid Infection Control Screening in Hospitals
As antimicrobial resistance spreads worldwide, healthcare-associated infections are placing a growing burden on hospitals, increasing the need for faster and broader diagnostic solutions.... Read more
Diagnostic Gaps Complicate Bundibugyo Ebola Outbreak Response in Congo
In eastern Democratic Republic of the Congo, communities are confronting a resurgence of Bundibugyo ebolavirus, a rarer species for which no vaccines or treatments have been approved. Ebola is a highly... Read more
Study Finds Hidden Mpox Infections May Drive Ongoing Spread
Mpox continues to circulate despite vaccination, and many cases show no known link to a symptomatic partner. The role of people without symptoms has remained uncertain, limiting clarity on how transmission persists.... Read more
Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals
Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read morePathology
view channel
Rapid AI Tool Predicts Cancer Spatial Gene Expression from Pathology Images
Gene expression profiling can inform tumor biology and treatment selection, but spatial assays remain costly and time-consuming. Results can take weeks and cost thousands of dollars, limiting large-scale... Read more
AI Pathology Test Receives FDA Breakthrough for Bladder Cancer Risk Stratification
Non–muscle invasive bladder cancer has highly variable outcomes, complicating surveillance and treatment planning. Risk assessment typically relies on stage, grade, and tumor size, leaving uncertainty... Read moreTechnology
view channel
AI-Enabled Assistant Unifies Molecular Workflow Planning and Support
Clinical laboratories and research groups face increasingly complex molecular workflows and expanding technical documentation spread across multiple systems. Fragmented digital tools can slow experiment... Read more
AI Tool Automates Validation of Laboratory Software Configuration Changes
Regulated laboratories face heavy documentation and requalification demands when software configurations change, slowing improvements and discouraging beneficial updates. A new capability now automates... Read moreIndustry
view channel
Strategic Collaboration Advances RNA Foundation Models for Precision Oncology
Bulk RNA sequencing is increasingly used to study tumor biology, but standard analyses often reduce results to gene-level summaries that miss important transcript variants and mutation patterns.... Read more








